Comparison of impurity profiles of lipiblock® vs. orlistat using HPLC and LC-MS/MS
Carregando...
Fontes externas
Fontes externas
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Tipo
Artigo
Direito de acesso
Acesso restrito
Fontes externas
Fontes externas
Resumo
Comparative HPLC-UV and LC-MS/MS studies of impurity profiles of a reference sample (Xenical®, F. Hoffmann-La Roche Ltd., Switzerland) vs. generic (Lipiblock®, EMS-Sigma Pharma, a generic drug) were carried out with ethanol extracts of commercial samples. The generic formulation contained higher levels of common impurities as well as a considerable number of impurities not found in the reference product. The detected impurity profile of Lipiblock® revealed that it most likely is based on fermentation. Since the effect of the impurities is unknown, at this point fully synthetic Xenical® appears to offer a better safety margin than Lipiblock® which, however, compares quite well to other generic formulations.
Descrição
Palavras-chave
Generics , HPLC-MS/MS , HPLC-UV , Orlistat , cobese , generic drug , lipiblock , orsoten , rotipuran , suprapur , tetrahydrolipstatin , unclassified drug , controlled study , drug formulation , drug impurity , drug safety , drug structure , fermentation , high performance liquid chromatography , intermethod comparison , liquid chromatography , mass spectrometry
Idioma
Inglês
Citação
Latin American Journal of Pharmacy, v. 31, n. 1, p. 91-96, 2012.
